What is the Fund?

Dr. Tanya Watt, the First Sam Robb Fellow

Dr. Tanya Watt, the First Sam Robb Fellow

Proceeds from the Sam Robb Fund will be used for two primary purposes. First, the fund will support the Sam Robb Fellow at the Aflac Cancer Center and Blood Disorders Services of Children’s Healthcare of Atlanta and Emory University School of Medicine. We believe it is critically important to help train the pediatric oncologists of tomorrow, so that they are fully prepared for a lifetime of excellence in patient care, teaching and research – just like the doctors who cared for Sam. We know that one of these young doctors may make significant contributions to finding cures for childhood cancers, and we know that Sam would be proud to support their training. We are also proud to be able to help Emory and the Aflac Cancer Center and Blood Disorder’s Service of Children’s Healthcare of Atlanta attract some of the nation’s best and brightest young doctors. These doctors care for children with cancer with unmatched skill and dedication, and the importance of providing them with the very best training and preparation for this vital and difficult work cannot be overstated.

Secondly, proceeds from the Sam Robb Fund will be used to help defray the costs of prosthetic devices for children with a cancer diagnosis who cannot afford to purchase and/or maintain them. Sam was determined to live life to the fullest and never let cancer rob him of the joys of life. Sam would want to encourage other children to follow his example, and through the Sam Robb Prosthetic Scholarship Fund, he will do that. The hope is that with the proper prosthetic devices, Sam will inspire childhood cancer survivors to return to a lifestyle that brings them happiness.

Introducing our new Research Fellow, Dr. Nicole Schlesinger

Dr. Nicole Schlesinger, the Second Sam Robb Research Fellow

Dr. Nicole Schlesinger, the Second Sam Robb Research Fellow

Dr. Schlesinger grew up in Long Island New York,  she went to Cornell University for undergraduate training and New York Medical College for medical school. Her pediatric residency was in Denver Colorado. Dr. Schlesinger hopes to do research in targeted drug therapies for childhood malignancies.